TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
29.19
-0.08 (-0.27%)
Mar 9, 2026, 4:00 PM EDT - Market closed
TG Therapeutics Employees
TG Therapeutics had 399 employees as of December 31, 2025. The number of employees increased by 61 or 18.05% compared to the previous year.
Employees
399
Change (1Y)
61
Growth (1Y)
18.05%
Revenue / Employee
$1,544,579
Profits / Employee
$1,120,749
Market Cap
4.31B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ACADIA Pharmaceuticals | 798 |
| ADMA Biologics | 685 |
| Crinetics Pharmaceuticals | 594 |
| Amicus Therapeutics | 511 |
| Apogee Therapeutics | 261 |
| Structure Therapeutics | 220 |
| Centessa Pharmaceuticals | 114 |
| Erasca | 103 |
TGTX News
- 14 hours ago - Data Published in Neurology and Therapy Demonstrate Significant Reductions in Relapse and MRI Activity with BRIUMVI® in People with Highly Active Relapsing Multiple Sclerosis - GlobeNewsWire
- 3 days ago - TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting - GlobeNewsWire
- 7 days ago - Precision BioSciences Receives $7.5M in Proceeds from TG Therapeutics for Azer-cel Clinical Milestone in Multiple Sclerosis - Business Wire
- 10 days ago - TG Therapeutics: 'Strong Buy' On BRIUMVI's Massive Growth And Possible Expansion - Seeking Alpha
- 11 days ago - TG Therapeutics, Inc. (TGTX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue Guidance - GlobeNewsWire
- 14 days ago - TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update - GlobeNewsWire
- 4 weeks ago - TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis - GlobeNewsWire